REGENXBIO Balance Sheet Health
Financial Health criteria checks 4/6
REGENXBIO has a total shareholder equity of $311.7M and total debt of $94.1M, which brings its debt-to-equity ratio to 30.2%. Its total assets and total liabilities are $574.0M and $262.2M respectively.
Key information
30.2%
Debt to equity ratio
US$94.05m
Debt
Interest coverage ratio | n/a |
Cash | US$275.26m |
Equity | US$311.74m |
Total liabilities | US$262.23m |
Total assets | US$573.97m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RB0's short term assets ($335.0M) exceed its short term liabilities ($130.3M).
Long Term Liabilities: RB0's short term assets ($335.0M) exceed its long term liabilities ($132.0M).
Debt to Equity History and Analysis
Debt Level: RB0 has more cash than its total debt.
Reducing Debt: RB0's debt to equity ratio has increased from 0% to 30.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RB0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if RB0 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.